SCHEMBL8699834

SCHEMBL8699834

C[SiH](C)OC[C@@]1(C(C)(C)C)CC(O)CN1C(=O)OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.40
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
AGTR2 P50052 1/20 0.38
CYP2C19 P33261 1/20 0.37
POLB P06746 1/20 0.37
HTT P42858 1/20 0.36
PREP P48147 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CACNA1G O43497 1/20 0.36
CACNA1H O95180 1/20 0.36
CACNA1I Q9P0X4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3295186 1.00 HTR2C (0.40) HTR2CPDK1PDK2PDK3PDK4
SCHEMBL8701753 0.80 NPC1 (0.42) HTR2CPDK1PDK2PDK3PDK4
SCHEMBL8701759 0.80 NPC1 (0.42) HTR2CPDK1PDK2PDK3PDK4
SCHEMBL7576836 0.79 HTR2C (0.37) HTR2CPDK1PDK2PDK3PDK4
SCHEMBL4698979 0.78 NR1H2 (0.36)
SCHEMBL2502213 0.75 HTR2C (0.46) HTR2CSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL2146179 0.75 HTR2C (0.46) HTR2CSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL18340933 0.75 HTR2C (0.46) HTR2CSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL5491000 0.74 SMN1; SMN2 (0.43) HTR2CSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL2435139 0.73 SMN1; SMN2 (0.46) HTR2CPDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760029-A TREATING CANCER METASTASIS, DIABETIC RETINOPATHY, NEOVASCULAR GLAUCOMA, THROMBOSIS, RESTENOSIS, OSTEOPOROSIS, MACULAR DEGENERATION THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-02 US disclosed